For the quarter ending 2026-03-31, MIRA has $9,463,736 in assets. $114,761 in debts. $4,815,031 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 4,815,031 | 6,346,921 | 2,641,539 | 730,475 |
| Prepaid expenses | 21,748 | 28,146 | 61,936 | 102,404 |
| Short-term investments | 4,591,518 | 4,683,099 | 4,894,366 | - |
| Total current assets | 9,428,297 | 11,058,166 | 7,597,841 | 832,879 |
| Related party receivable | 35,439 | 35,439 | 35,439 | 35,439 |
| Total assets | 9,463,736 | 11,093,605 | 7,633,280 | 868,318 |
| Accrued liabilities | - | - | - | 0 |
| Trade accounts payable and accrued liabilities | 34,008 | 129,203 | 83,926 | 298,459 |
| Due to related party | - | 572,865 | - | - |
| Accrued compensation related party | 80,753 | - | - | - |
| Total current liabilities | 114,761 | 702,068 | 83,926 | 298,459 |
| Total liabilities | 114,761 | 702,068 | 83,926 | 298,459 |
| Common stock, no par value 100,000,000 shares authorized, 42,022,087 and 41,938,587 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 4,202 | 4,194 | 3,951 | 1,739 |
| Additional paid-in capital | 50,075,131 | 49,967,549 | 41,142,288 | 33,027,332 |
| Accumulated deficit | -40,730,358 | -39,580,206 | -33,596,885 | -32,459,212 |
| Total stockholders equity | 9,348,975 | 10,391,537 | 7,549,354 | 569,859 |
| Total liabilities and stockholders equity | 9,463,736 | 11,093,605 | 7,633,280 | 868,318 |
MIRA PHARMACEUTICALS, INC. (MIRA)
MIRA PHARMACEUTICALS, INC. (MIRA)